Cannabis Science Inc (CBIS) 0.0370 $CBIS
Subsidiary of ImmunoClin Corporation (IMCL) receives controlled drug license in the United Kingdom
PR Newswire - Thu Apr 02, 11:51AM CDT
ImmunoClin Corporation (OTC Markets: IMCL), a healthcare company specialized in personalized medicine, announces that its wholly owned subsidiary, ImmunoClin Ltd., received a controlled drug license from the UK government to possess, supply and produce schedule 1 drugs in its UK laboratory.
Cannabis Science (CBIS) Names Investor Relations Veteran Of Leading Companies To Head Its Investor Relations Initiatives
PR Newswire - Tue Mar 31, 7:37AM CDT
Cannabis Science, Inc. (OTCQB: CBIS) today announced it has entered into a one-year agreement with Derwin A. Wallace to provide financial and investor relations services for the Company. Mr. Wallace will focus on developing and expanding the Company's financial communications with the institutional and retail investment communities and initiate coverage from research analysts through a comprehensive financial and investor relations program.
Penny Stocks Buzz for Blue Water, Imageware Systems, Megola, Baltia Air Lines, Cannabis Science, and MEDL Mobile
PR Newswire - Mon Mar 30, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Blue Water (OTCBB: BLUU), Imageware Systems (OTCMKTS: IWSY), Megola (OTCMKTS: MGON), Baltia Air Lines (OTCMKTS: BLTA), Cannabis Science (OTCMKTS: CBIS), and MEDL Mobile (OTCMKTS: MEDL).
After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis Science, Inc. Reports Strong Customer Interest
PR Newswire - Thu Mar 26, 9:09AM CDT
Choosing to present its products to the world at this year's Spannabis Fair, held March 20-22 in Barcelona, Spain, Cannabis Science, Inc. (OTCQB: CBIS) immediately began meeting with representatives of businesses and organizations interested in providing the products to their customers from across Spain.
Former National Institute Of Health (NIH) Scientist Allen A. Herman, M.B., Ch.B., Ph.D., Joins The Cannabis Science Scientific Advisory Board (SAB)
PR Newswire - Fri Mar 20, 10:01AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that accomplished scholar, epidemiologist, and public health physician Allen A. Herman, M.B., Ch.B., Ph.D. has joined its scientific advisory board.
Cannabis Science (CBIS) Retains Cohen Grassroots Research Firm To Initiate Coverage Beginning With A 115-Page Analytical Report
PR Newswire - Wed Mar 18, 5:02AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that Cohen Grassroots Research, Inc. (CGR), Wall Street's leading independent micro-cap and cannabis research firm, has been retained by the Company to initiate intricate analytical coverage of the Company.
Cannabis Science Subsidiary Michigan Green Technologies (MGT) Announces Key Progress With its Michigan State Initiatives & A New Advisory Board with Significant Board Members
PR Newswire - Fri Mar 13, 12:59PM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development related consulting, is please to announce key progress with its subsidiary, Michigan Green Technologies.
Senators Propose Federal Medical Cannabis Bill; Would Eliminate Schedule 1 Status; Cannabis Stocks Rally
ACCESSWIRE - Thu Mar 12, 2:34PM CDT
LAKE FOREST, CA / ACCESSWIRE / March 12, 2015 / MJIC, Inc., a venture capital firm focused exclusively on the legal cannabis industry, is pleased to provide the following market update regarding breaking news impacting the market:
Cannabis Science (CBIS) Applauds 'Historic Step Forward For Nation's Suffering Patients' As U.S. Senate Introduces A Medical Marijuana Bill To End Federal Prohibition
PR Newswire - Wed Mar 11, 7:43AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in the development of cannabis-based medicine, called today's introduction of a United States Senate bill that would end the federal ban on medical marijuana "a science-based blessing for patients across the United States" and a "common sense move that will contribute to significant new science-based research."
Cannabis Science Set to Release its First Line of European Products at Spannabis 2015, Taking Place in Barcelona, Spain from March 20th until the 22nd
PR Newswire - Mon Mar 09, 7:44AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce it is set to release its first line of European products that will feature Cannabis Science proprietary formulations developed in Spain and the Netherlands at Spannabis 2015, taking place in Barcelona, Spain from March 20th until the 22nd, the largest Cannabis conference in the world. Other European markets will follow as jurisdictional laws permit.
6 Penny Stocks That Could Be Killing Your Portfolio Right Now
at The Street - Mon Mar 09, 7:17AM CDT
Openfolio surveyed the portfolios of its pool of over 20,000 investors to see the effect penny stocks have on overall performance.
APP: 0.63 (+0.02), ZNGA: 2.49 (+0.11)
Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 57.97 (+0.06), FULL: 3.55 (-0.03), CARA: 10.93 (+0.27)
CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist
PR Newswire - Tue Mar 03, 8:03AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in the development of cannabis-based medicine, today announced two important developments: It launched its toll-free call center in preparation for its multiple global product launches, and CEO Raymond C. Dabney recently shared his industry views in the Chicago HR Examiner.
Is Now The Time To Pounce On The Pot Business?
Nicholas Kitonyi - at Seeking Alpha - Mon Mar 02, 2:09PM CST
GWPH: 91.32 (+0.38), ABBV: 62.00 (+1.68), BMY: 64.64 (+1.18)
Marijuana Stocks: Seeking Liquidity
Matthew Finston - at Seeking Alpha - Mon Mar 02, 7:24AM CST
Cannabis Science Highlights Additional Attendees at the Washington DC, African Union, CFA African Healthcare Infrastructure Forum and Brainstorm on February 6, 2015
PR Newswire - Wed Feb 11, 12:20PM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015.
Cannabis Science President & CEO, Raymond C. Dabney is named Vice Chair of the CFA Africa Healthcare Infrastructure Initiative Committee
PR Newswire - Mon Feb 09, 8:30AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today announced the appointment of Cannabis Science President & CEO, Raymond C. Dabney as Vice Chair of the newly launched Constituency for Africa (CFA) Africa Healthcare Infrastructure Committee. ( www.cfa-network.org ) (https://www.facebook.com/pages/Constituency-for-Africa/347822291974589 )
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 91.32 (+0.38), FULL: 3.55 (-0.03), CARA: 10.93 (+0.27)
Cannabis Science Reports 'CBS This Morning' Interview; US Surgeon General Believes Medical Cannabis 'Can Be Helpful' and Suggests Federal Policy Should Be Driven by Scientific Data
PR Newswire - Thu Feb 05, 6:55AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today applauds US Surgeon General Vivek Murphy who announced yesterday in an interview on 'CBS This Morning' that "we have some preliminary data showing that for certain medical conditions and symptoms that marijuana can be helpful." Surgeon General Vivek also said that scientific data should drive federal medical cannabis policy, and he is "very interested to see where that data takes us."
Subsidiary of ImmunoClin Corporation (IMCL) receives controlled drug license in the United Kingdom
PR Newswire - Thu Apr 02, 11:51AM CDT
ImmunoClin Corporation (OTC Markets: IMCL), a healthcare company specialized in personalized medicine, announces that its wholly owned subsidiary, ImmunoClin Ltd., received a controlled drug license from the UK government to possess, supply and produce schedule 1 drugs in its UK laboratory.
Cannabis Science (CBIS) Names Investor Relations Veteran Of Leading Companies To Head Its Investor Relations Initiatives
PR Newswire - Tue Mar 31, 7:37AM CDT
Cannabis Science, Inc. (OTCQB: CBIS) today announced it has entered into a one-year agreement with Derwin A. Wallace to provide financial and investor relations services for the Company. Mr. Wallace will focus on developing and expanding the Company's financial communications with the institutional and retail investment communities and initiate coverage from research analysts through a comprehensive financial and investor relations program.
Penny Stocks Buzz for Blue Water, Imageware Systems, Megola, Baltia Air Lines, Cannabis Science, and MEDL Mobile
PR Newswire - Mon Mar 30, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Blue Water (OTCBB: BLUU), Imageware Systems (OTCMKTS: IWSY), Megola (OTCMKTS: MGON), Baltia Air Lines (OTCMKTS: BLTA), Cannabis Science (OTCMKTS: CBIS), and MEDL Mobile (OTCMKTS: MEDL).
After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis Science, Inc. Reports Strong Customer Interest
PR Newswire - Thu Mar 26, 9:09AM CDT
Choosing to present its products to the world at this year's Spannabis Fair, held March 20-22 in Barcelona, Spain, Cannabis Science, Inc. (OTCQB: CBIS) immediately began meeting with representatives of businesses and organizations interested in providing the products to their customers from across Spain.
Former National Institute Of Health (NIH) Scientist Allen A. Herman, M.B., Ch.B., Ph.D., Joins The Cannabis Science Scientific Advisory Board (SAB)
PR Newswire - Fri Mar 20, 10:01AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that accomplished scholar, epidemiologist, and public health physician Allen A. Herman, M.B., Ch.B., Ph.D. has joined its scientific advisory board.
Cannabis Science (CBIS) Retains Cohen Grassroots Research Firm To Initiate Coverage Beginning With A 115-Page Analytical Report
PR Newswire - Wed Mar 18, 5:02AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that Cohen Grassroots Research, Inc. (CGR), Wall Street's leading independent micro-cap and cannabis research firm, has been retained by the Company to initiate intricate analytical coverage of the Company.
Cannabis Science Subsidiary Michigan Green Technologies (MGT) Announces Key Progress With its Michigan State Initiatives & A New Advisory Board with Significant Board Members
PR Newswire - Fri Mar 13, 12:59PM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development related consulting, is please to announce key progress with its subsidiary, Michigan Green Technologies.
Senators Propose Federal Medical Cannabis Bill; Would Eliminate Schedule 1 Status; Cannabis Stocks Rally
ACCESSWIRE - Thu Mar 12, 2:34PM CDT
LAKE FOREST, CA / ACCESSWIRE / March 12, 2015 / MJIC, Inc., a venture capital firm focused exclusively on the legal cannabis industry, is pleased to provide the following market update regarding breaking news impacting the market:
Cannabis Science (CBIS) Applauds 'Historic Step Forward For Nation's Suffering Patients' As U.S. Senate Introduces A Medical Marijuana Bill To End Federal Prohibition
PR Newswire - Wed Mar 11, 7:43AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in the development of cannabis-based medicine, called today's introduction of a United States Senate bill that would end the federal ban on medical marijuana "a science-based blessing for patients across the United States" and a "common sense move that will contribute to significant new science-based research."
Cannabis Science Set to Release its First Line of European Products at Spannabis 2015, Taking Place in Barcelona, Spain from March 20th until the 22nd
PR Newswire - Mon Mar 09, 7:44AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce it is set to release its first line of European products that will feature Cannabis Science proprietary formulations developed in Spain and the Netherlands at Spannabis 2015, taking place in Barcelona, Spain from March 20th until the 22nd, the largest Cannabis conference in the world. Other European markets will follow as jurisdictional laws permit.
6 Penny Stocks That Could Be Killing Your Portfolio Right Now
at The Street - Mon Mar 09, 7:17AM CDT
Openfolio surveyed the portfolios of its pool of over 20,000 investors to see the effect penny stocks have on overall performance.
APP: 0.63 (+0.02), ZNGA: 2.49 (+0.11)
Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 57.97 (+0.06), FULL: 3.55 (-0.03), CARA: 10.93 (+0.27)
CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist
PR Newswire - Tue Mar 03, 8:03AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in the development of cannabis-based medicine, today announced two important developments: It launched its toll-free call center in preparation for its multiple global product launches, and CEO Raymond C. Dabney recently shared his industry views in the Chicago HR Examiner.
Is Now The Time To Pounce On The Pot Business?
Nicholas Kitonyi - at Seeking Alpha - Mon Mar 02, 2:09PM CST
GWPH: 91.32 (+0.38), ABBV: 62.00 (+1.68), BMY: 64.64 (+1.18)
Marijuana Stocks: Seeking Liquidity
Matthew Finston - at Seeking Alpha - Mon Mar 02, 7:24AM CST
Cannabis Science Highlights Additional Attendees at the Washington DC, African Union, CFA African Healthcare Infrastructure Forum and Brainstorm on February 6, 2015
PR Newswire - Wed Feb 11, 12:20PM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015.
Cannabis Science President & CEO, Raymond C. Dabney is named Vice Chair of the CFA Africa Healthcare Infrastructure Initiative Committee
PR Newswire - Mon Feb 09, 8:30AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today announced the appointment of Cannabis Science President & CEO, Raymond C. Dabney as Vice Chair of the newly launched Constituency for Africa (CFA) Africa Healthcare Infrastructure Committee. ( www.cfa-network.org ) (https://www.facebook.com/pages/Constituency-for-Africa/347822291974589 )
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 91.32 (+0.38), FULL: 3.55 (-0.03), CARA: 10.93 (+0.27)
Cannabis Science Reports 'CBS This Morning' Interview; US Surgeon General Believes Medical Cannabis 'Can Be Helpful' and Suggests Federal Policy Should Be Driven by Scientific Data
PR Newswire - Thu Feb 05, 6:55AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, today applauds US Surgeon General Vivek Murphy who announced yesterday in an interview on 'CBS This Morning' that "we have some preliminary data showing that for certain medical conditions and symptoms that marijuana can be helpful." Surgeon General Vivek also said that scientific data should drive federal medical cannabis policy, and he is "very interested to see where that data takes us."
